---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039584"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:27:29.898388+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Impact BioMedical exchanges majority holder's common shares for preferred; enacts 1-for-55 reverse stock split

## Summary
- Exchanged 60,496,091 common shares held by majority shareholder DBH for 60,496,091 Series A Convertible Preferred shares.
- Series A preferred votes on as-converted basis (1:1), no dividend rights, convertible to common 1:1 after 75 days.
- Reverse stock split of issued common stock at 1-for-55 ratio effected on October 31, 2023; authorized shares unchanged.
- DBH remains a shareholder with 1,178,882 common shares post-exchange; Board and majority stockholder approved split.
- Series A preferred carries liquidation preference equal to net assets; no amendment to articles executed for split.

## SEC filing metadata
- accession: 0001493152-23-039584
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000149315223039584/0001493152-23-039584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000149315223039584/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039584
- JSON: https://secwatch.observer/filing/0001493152-23-039584.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039584.txt

## Key facts
- Material Agreements
  IMPACT BIOMEDICAL INC. entered into Share Exchange Agreement with DSS BioHealth Security, Inc. (effective 2023-10-31).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: DSS BioHealth Security, Inc.
  - Effective: 2023-10-31
  source text: Impact BioMedical, Inc. (the “Company”), entered into a Share Exchange Agreement (the “Exchange Agreement”) with DSS BioHealth Security, Inc. (“DBH”), pursuant to which, DBH agreed to exchange 60,496,091 shares of the Company’s common stock for 60,496,091 shares of Series A Convertible Preferred Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834105/000149315223039584/0001493152-23-039584-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.